Global /Sweden /Healthcare /Medical Devices /MAGNA

Magnasense AB

MAGNA

• STO: MAGNA • Delayed

0.0123SEK 46%

0.0013 USD

As of 7 June 2026, Magnasense AB has a market cap of $4.09M USD, ranking #45201 globally and #742 in Sweden. It ranks #4002 in the Healthcare sector, and #840 in the Medical Devices industry.

Global Rank

45201

Country Rank

742

Sector Rank

4002

Industry Rank

840

Key Stats

Market Cap

$4.09MUSD

38.37M SEK

Enterprise Value

$7.59MUSD

71.94M SEK

EBITDA (TTM)

-$2.73MUSD

-25.87M SEK

Net Income (TTM)

-$6.84MUSD

-64.12M SEK

PB Ratio

-0.8

Company Profile

Country (HQ)

Sweden

Sector

Healthcare

Industry

Medical Devices

CEO

Marco Witteveen open_in_new

Employees

Founded

2019

Website

magnasense.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
46%	-14%	120%	284%	-85%	-86%	-91%	-100%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
Nasdaq Stockholm (STO) MIC: XSTO PRIMARY	MAGNA AegirBio AB Ordinary Shares ISIN: SE0014401121 Shares Out.: Shares Outstanding: 2.646B¹ Shares Float: 1.519B² TV: TradingView: OMXSTO: MAGNA SA: Stock Analysis: STO: MAGNA YF: Yahoo Finance: MAGNA.ST GF: Google Finance: STO: MAGNA BA: Barron's: MAGNA MS: Morningstar: XSTO: MAGNA	0.0123 SEK	TV: TradingView: OMXSTO: MAGNA SA: Stock Analysis: STO: MAGNA YF: Yahoo Finance: MAGNA.ST GF: Google Finance: STO: MAGNA BA: Barron's: MAGNA MS: Morningstar: XSTO: MAGNA

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Magnasense AB

Magnasense AB develops and commercializes diagnostic tests for monitoring and optimizing the dosage of biological drugs. The company develops a testing platform for oral health, therapeutic drug monitoring, and infectious diseases. It develops Veritope technology used to optimize the dosage of biological drugs to patients; and the MagniaReader platform. The company was formerly known as AegirBio AB (publ) and changed its name to Magnasense AB in July 2024. Magnasense AB was incorporated in 2019 and is based in Lund, Sweden.

Similar Companies

Industry: Medical Devices (Sweden)

Name	Market Cap (USD) diff.	PE	Country
Getinge AB (publ) STO: GETI-B	$5.59B 52.4B SEK 136K%	22.2	Sweden
S SciBase Holding AB STO: SCIB	$4.85B 45.5B SEK 118K%	-	Sweden
Elekta AB (publ) STO: EKTA-B	$2.23B 20.86B SEK 54K%	-	Sweden
Vitrolife AB (publ) STO: VITR	$1.59B 14.87B SEK 39K%	-	Sweden
Bonesupport Holding AB (publ) STO: BONEX	$1.53B 14.32B SEK 37K%	78.5	Sweden
Xvivo Perfusion AB (publ) STO: XVIVO	$907.38M 8.5B SEK 22K%	115.1	Sweden

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 4M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 4M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 4M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 3M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 3M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 2M%	22.2	Ireland

chevron_leftBack